answer text |
<p>Off-patent drugs are those whose patent period has expired and they are widely
used in the National Health Service now. Drugs can also be prescribed ‘off-label’
outside of their licensed indication(s) to individual patients where doctors consider
it is clinically appropriate to do so. Prescribing decisions are rightly a matter
for clinicians in discussion with their patients.</p><p> </p><p> </p><p> </p><p>My
Rt. hon. Friend the Secretary of State has had no discussions with charities about
the use of off-patent drugs for new indications since 2 July. Officials have had several
discussions with the Breast Cancer Campaign covering their views on medicines licences,
implementation of National Institute for Health and Care Excellence guidelines and
planning the roundtable discussion on adoption of new evidence into clinical practice.
There have also been ongoing discussions with Cancer Research UK on the use of aspirin
to help prevent certain cancers.</p><p> </p><p><strong> </strong></p><p> </p>
|
|